BRIEF published on 04/05/2024 at 13:05, 1 year 7 months ago Nordea Bank Abp Announces Managers' Transactions Involving Martin Persson Market Abuse Regulation Nordea Bank Abp Managers' Transactions Share-based Incentive Martin Persson
BRIEF published on 04/05/2024 at 13:05, 1 year 7 months ago Nordea Bank Abp Announces Management Transaction Involving Snorre Storset Market Abuse Regulation Nordea Bank Abp Share-based Incentive Management Transactions Snorre Storset
BRIEF published on 04/05/2024 at 13:05, 1 year 7 months ago Senior Manager of Nordea Bank Abp Receives Share-Based Incentive Corporate Governance Nordea Bank Abp EU Market Abuse Regulation Share-based Incentive Sara Mella
BRIEF published on 04/05/2024 at 13:05, 1 year 7 months ago Nordea Bank Announces Share-Based Incentive Transaction for Chief Audit Executive Virpi Vuorinen Market Abuse Regulation Corporate Governance Nordea Bank Abp Share-based Incentive Virpi Vuorinen
BRIEF published on 04/05/2024 at 13:05, 1 year 7 months ago Nordea Bank Abp Announces Managers' Transactions Involving Ulrika Romantschuk Market Abuse Regulation Nordea Bank Abp Managers' Transactions Share-based Incentive Ulrika Romantschuk
PRESS RELEASE published on 04/05/2024 at 13:00, 1 year 7 months ago Nordea Bank Abp: Managers' transactions - Gadeberg Nordea Group Leadership Team member Christina Gadeberg receives 14,463 shares in Nordea Bank Abp according to Market Abuse Regulation notification Market Abuse Regulation Nordea Bank Abp Managers' Transactions Share-based Incentive Christina Gadeberg
PRESS RELEASE published on 04/05/2024 at 13:00, 1 year 7 months ago Nordea Bank Abp: Managers' transactions - Ekman Nordea Bank Abp reports Managers' transactions by Erik Ekman, a member of Nordea Group Leadership Team, receiving 21,667 shares under Market Abuse Regulation Market Abuse Regulation Nordea Bank Abp Managers' Transactions Share-based Incentive Erik Ekman
PRESS RELEASE published on 04/05/2024 at 13:00, 1 year 7 months ago Nordea Bank Abp: Managers transactions Vang-Jensen Nordea Bank Abp's President and Group CEO, Frank Vang-Jensen, receives 43,727 shares in the company as part of a share-based incentive, in compliance with the Market Abuse Regulation Market Abuse Regulation Nordea Bank Abp Managers' Transactions Frank Vang-Jensen Share-based Incentive
PRESS RELEASE published on 04/05/2024 at 13:00, 1 year 7 months ago Nordea Bank Abp: Managers' transactions - Smith Nordea Bank Abp's Chief Financial Officer Ian Smith receives 26,160 shares as part of a share-based incentive. Managers' transactions disclosed under the Market Abuse Regulation Market Abuse Regulation Nordea Bank Abp Managers' Transactions Share-based Incentive Ian Smith
PRESS RELEASE published on 04/05/2024 at 13:00, 1 year 7 months ago Nordea Bank Abp: Managers' transactions - Graham Nordea Bank Abp's Group Leadership Team member James Graham receives 7,396 shares in the company. Transaction notification under EU Market Abuse Regulation Market Abuse Regulation Nordea Bank Abp Managers' Transactions EU Market Abuse Regulation Share-based Incentive
Published on 12/05/2025 at 02:35, 4 hours 35 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 10 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 5 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 10 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 39 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 19 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 44 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 55 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 59 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 10 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
